Standout Papers

Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute cor... 2020 2026 2022 2024202
  1. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial (2020)
    Marieke E. Gimbel, Laura M. Willemsen et al. The Lancet

Immediate Impact

20 standout
Sub-graph 1 of 10

Citing Papers

The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease
2024 Standout
Use of Artificial Intelligence in Improving Outcomes in Heart Disease: A Scientific Statement From the American Heart Association
2024 Standout
2 intermediate papers

Works of Rik Hermanides being referenced

Early or late intervention in patients with transient ST‐segment elevation acute coronary syndrome: Subgroup analysis of the ELISA‐3 trial
2016

Author Peers

Author Last Decade Papers Cites
Rik Hermanides 254 163 68 14 290
F.W.A. Verheugt 273 135 80 18 303
Andrea Podczeck-Schweighofer 252 108 31 13 266
Bart J. de Smet 268 167 137 11 333
Rocco Edoardo Stio 131 97 45 17 168
Marieke E. Gimbel 243 114 18 10 261
Benjamin E. Peterson 158 67 40 15 244
Giorgio Baralis 241 183 145 18 312
L. R. van der Wieken 262 170 71 16 332
Ronald Hödl 256 87 41 21 317
Dana Bilkova 239 147 64 11 276

All Works

Loading papers...

Rankless by CCL
2026